The primary purpose of the Idaho Perinatal Project is to reduce maternal and infant morbidity and mortality and to improve pregnancy outcomes throughout the state of Idaho.
Our goals include the creation of a database for maternal/child outcomes; correlate, analyze, and make recommendations regarding maternal/child statistical data for the state of Idaho; provide education to perinatal health care professionals and the general public; and become a main resource and advocate in maternal/infant health.
The aim of PRIORITY is to collect high yield data to answer urgent questions that inform care and counseling of pregnant women and their newborns.
A collaborative group from the University of California San Francisco are leading the study.
They are enrolling patients from any hospital across the country. Please consider referring patients and passing this information along to your colleagues and networks.
TO REFER A PATIENT (Suspected/Under Investigation OR Confirmed Case, any language spoken): You do not need IRB or Research Ethics Board approval at your site because no research activities will occur there. Please ask the patient if she is willing to have her contact information shared. If yes, you can click here to Refer a Patient, or call/text 415-754-3729, or email at PRIORITYCOVID19@ucsf.edu.
The patient can also contact then herself. For Patients: Enroll in PRIORITY . They will then reach out directly to her to consent, enroll, and begin data collection.
Here are more details about the study procedures: Information for Providers. If you are willing, please circulate to your colleagues.
CDC recommends that pregnant women should not travel to areas with risk of Zika.This includes all areas with documented or likely Zika virus transmission (see WHO categories for more information). If a pregnant woman must travel to one of these areas, she should be counseled to strictly follow steps to avoid mosquito bites and prevent sexual transmission of Zika during and after the trip.
Pregnant women with Zika symptoms and with possible Zika exposure should be tested for Zika virus infection.Possible Zika exposure includes living in or having recently traveled to an area with documented or likely Zika virus transmission, or having had sex without a condom with a person who lives in or has traveled to an area with risk of Zika.
Pregnant women with no Zika symptoms but who have ongoing Zika exposure should be offered Zika testing.Testing is no longer routinely recommended for pregnant women with no Zika symptoms who have recent possible exposure to Zika but no ongoing exposure. However, testing should be considered using a shared decision-making model that includes pretest counseling, individualized risk assessment, clinical judgment, patient preferences, and the jurisdiction's recommendations.
Are you a woman who is thinking about getting pregnant?
Are you a man who is going to have unprotected sex with a woman who is pregnant or may become pregnant?
If your answer to all of these questions is "no," there is arguably no reason for you to get tested. Only 20% people who contract the virus will even develop any symptoms, and those who do will experience only mild and short-lived discomfort.
If you answered "yes" to any of these questions, however, you should contact your doctor about being tested for Zika.
Consumer Reports found three products to be most effective in combating the mosquito known for carrying Zika: Sawyer Fisherman's Formula Picaridin, Natrapel 8 Hour and Off! Deepwoods VIII. 25% DEET or 20% Oicardin that's the Jist
CDC expands Zika virus travel warning(website) The CDC has expanded to 22 the number of countries and territories pregnant women should not visit due to the risk of contracting Zika virus, a mosquito-transmitted disease that may be causing microencephaly in infants born to infected mothers. Although initial concern has focused on Brazil, where 3,893 suspected cases of microcephaly have been reported with a major uptick since 2010, the World Health Organization said today that the virus will likely reach all of the Americas except Chile and Canada.
Critical Congenital Heart Disease (CCHD) Screening(website) During the 2018 Idaho legislative session, rules were added to existing Idaho Administrative Code 16.02.12 - Procedures and Testing to be Performed on Newborn Infants, to include screening for critical congenital heart disease (CCHD) using pulse oximetry. Effective July 1, 2018 screening for CCHD is mandated for all Idaho newborns.
The Idaho Children's Trust Fund is dedicated to the prevention of child abuse and neglect through funding, educating, supporting and building awareness among community-based organizations who share our mission. One of the major ways we do this is our annual grants program: we offer grant funding within the $1,000-$5,000 range to programs that seek to prevent child abuse and neglect by increasing protective factors in order to strengthen families and promote well-being.
November 20, 2018 — Annual Grant Applications due to ICTF
January 22, 2019 — Annual Grant Award Decisions
May 1, 2019 — New Annual Grantee Project Start Date
My Birth Matters(website - 7/20/2018) Website designed to educate women about the overuse of C-sections and encourage them to engage with their care team to reduce their chances of having an avoidable C-section.
Cytomegalovirus (CMV) Resources(website - 7/5/2018) CMV infection can cause serious health problems for people with weakened immune systems, as well as babies infected with the virus before they are born.
World Breastfeeding Week Seed Grant Project(website - 6/12/2018) August 1-7 is set aside to celebrate the most sustainable, nutritious, species-specific feeding choice. Most families plan to breastfeed, yet statistics reflect moms abandoning their goals and stopping short of their mark. We must all come together to find solutions to the issues breastfeeders face. Commit now to celebrate this special event and lend your support to this great cause.
The recently published Practice Bulletin addressing gestational diabetes (Practice Bulletin # 190) updated the recommendations regarding pharmacologic management of women with gestational diabetes, describing that insulin is the preferred initial approach compared to the use of oral agents such as metformin. This recommendation has generated some controversy in the obstetric community. On January 29, 2018, the Society of Maternal-Fetal Medicine (SMFM) published a SMFM Statement entitled "Pharmacological Treatment of Gestational Diabetes", recommending that if pharmacologic management of diabetes is indicated, that metformin is a reasonable first-line alternative to insulin.
It is important to acknowledge that both ACOG and SMFM carefully reviewed available evidence, and in fact both organizations referenced many of the same publications in addressing efficacy, safety, and risks. ACOG's recommendation for insulin being the preferred initial approach was based on several issues, including
-Oral antidiabetic medications cross the placenta
-Long-term neonatal safety data for oral antidiabetic agents are lacking
-Summaries of current medical literature note poor trial quality while not being designed to assess equivalence when compared to insulin.
-SMFM also acknowledges these same concerns, and based on their interpretation of the evidence, concluded that metformin is a reasonable and safe first-line alternative to insulin.
Although these two organizational recommendations may seem to differ at first, they are in fact very similar. Both organizational recommendations acknowledge that metformin is a reasonable and appropriate alternative; the main difference is that ACOG recommends insulin as the preferred initial pharmacologic approach while SMFM recommends that metformin is a reasonable and appropriate first-line alternative agent. ACOG believes that these organizational recommendations, rather than being substantially different, are complementary, and importantly, provide accurate and current guidance to aid women in the informed decision-making process regarding the pharmacologic approach that best fits the individual woman's values and preferences.
The State Loan Repayment Program (SLRP) is a multi-discipline, state-based loan repayment program for practitioners working for a nonprofit or public entity located in federally-designated Health Professional Shortage Areas. The loan repayment is provided through a federal grant and every award must be matched $1 to $1 with funds provided by the practitioner’s employer. Participating sites must implement a sliding fee scale for low income and uninsured patients and accept Medicare and Medicaid. Loan repayment awards can range from $2,500- $25,000 per year. A two-year service obligation for full-time practitioners and four-year service obligation for part-time practitioners is required and sites must submit bi-annual reports during the funding period. Participants currently receiving loan repayment and fulfilling a service obligation are not eligible. For more information contact the Bureau of Rural Health and Primary Care at email@example.com or 208-334-0669. (10/9/2017)
Download your FREE Count the Kicks app(website - 8/7/2017) This app makes it simple to track your baby's normal movement pattern with the touch of your finger. Its daily text feature will even remind you when it?s time to start counting. If you notice a change in your baby's regular movement pattern, call your healthcare provider right away.
A Radio Interview with one of our Board Members about one of her current projects.
SURVEY - Incarcerated Pregnant Women(website) We are inviting all perinatal nurses to take a research survey. We need your input to better understand nursing care of incarcerated pregnant women in hospital settings. Your input is valuable, even if you have never cared for an incarcerated woman. Participation in this research survey will take approximately 10 minutes. It is voluntary. Your responses are anonymous. For each survey completed, the National Diaper Bank Network will receive $1, up to $1,200.
New 2017 edition of the reference Medications and Mothers' Milk is now available(emails) Now available in print, and as an online subscription, this worldwide-bestselling drug reference continues to provide readers with the most current, complete, and evidence-based information about what is known on the transfer of various medications into human milk, the use of radiopharmaceuticals, the use of chemotherapeutic agents, and vaccines in breastfeeding mothers. Email Annette Imperati for the Print edition and Reina Santana for an Online Subscription
Doctors perform first mother-to-daughter womb transplants(website) According to the Swedish university, a team of more than 10 surgeons transplanted uteruses into two women over the weekend "without complications." The surgeons had trained together for the procedure for several years.
Half of U.S. Women Weigh Too Much Before Getting Pregnant(website) CDC data from 2014 showed more than 25% of women were overweight and almost 25% were obese before becoming pregnant. The study found black, American Indian or Alaska Native women, along with those over age 40, were more likely to be obese.
How moms flu shot protects baby(website) In addition to protecting mothers during pregnancy, a flu shot administered during the first weeks of the third trimester may protect babies in the months before they can receive the vaccine themselves.
WHO declares public health emergency(website) The World Health Organization (WHO) declared a public health emergency Monday as it continues to investigate whether clusters of microcephaly and other neurological disorders are linked to the Zika virus.
CDC: US infant mortality rate drops(website) The rate of infant mortality in the US declined from 596.1 infant deaths per 100,000 live births in 2013 to 582.1 in 2014, the country's lowest level ever, according to a report from the CDC.
Elective Inductions and Cesareans 2012-2114(pdf) By population density, district, payment source, BMI, state of delivery, ethnicity, and race (2012-2014). Data based on the singleton deliveries prior to 39 weeks gestation, and are based on the obstetric estimate (OE) rather than the LMP-calculated gestation. The trend data were updated as well (2005-2014)
Study examines lithium as treatment for bipolar disorder in children(website) A study in Pediatrics showed almost 47% of children with bipolar disorder had "much improved" or "very much improved" symptoms eight weeks after taking a standard dose of lithium, which was gradually increased to the maximum dose if mood symptoms weren't controlled, compared with 21% of children on placebo. The findings, based on 81 patients ages 7 to 17, also revealed those on lithium had no significant weight gain and no serious drug-related side effects.
Nurses' Critical Role in Preventing Infant Sleep-Related Deaths(website) Did you know most infant sleep-related deaths are considered preventable? This is good news worth sharing! Because most babies are born in a hospital or birthing center, nurses are uniquely positioned to interact with virtually every new parent. This means nurses play a critical role in helping prevent these deaths.
New Progesterone Flyer from the March of Dimes(website) This flyer encourages women who have had a premature birth to speak with their doctor regarding the use of progesterone (17P) to increase the chances of having a full term baby in their next pregnancy.
FDA approval for new HPV vaccine(website) Gardasil 9 has potential to prevent approximately 90% of cervical, vulvar, vaginal and anal cancers. The vaccine is approved for females ages 9-26 and males 9-15.
"Let's Talk About It" Video series(website) Living Beyond Breast Cancer, (LBBC), Young Women's Initiative, "Developing Support and Evaluation Awareness for Young Breast Cancer Survivors" recently launched two new videos